Alembic Pharmaceuticals advanced 2.67% to Rs 1216.10 after the company received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Acitretin Capsules.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
